3,794 results match your criteria: "Centre d'investigation Clinique[Affiliation]"
Eur J Clin Invest
November 2024
Finnish Cardiovascular Research Center, University of Tampere, Tampere, Finland.
Background: Ceramide and phosphatidylcholine lipids-based risk score (CERT2) has shown a strong prognostic value in predicting cardiovascular (CV) events in patients with ischemic heart disease. This study aimed to investigate the prognostic value of CERT2 risk score in patients with heart failure (HF).
Methods: The current study combines data for 4234 subjects from the COMMANDER-HF trial and 1227 subjects from the GISSI-HF trial, which enrolled patients with a history of HF.
Arch Cardiovasc Dis
November 2024
Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital (CHU), 37, allées Jules-Guesde, 31000 Toulouse, France; Team Pharmacologie En Population cohorteS et biobanqueS (PEPSS), centre d'investigation clinique 1436, Toulouse University Hospital (CHU), 31000 Toulouse, France. Electronic address:
Glob Health Promot
November 2024
University of Bordeaux, INSERM, BPH, U1219, Mérisp/PHARES Equipe Labellisée Ligue Contre le Cancer, Bordeaux, France.
This article explores the role of population health intervention research (PHIR) in enhancing health promotion in France, stressing the importance of a more in-depth understanding and thorough analysis of healthcare interventions. Established in 2022, the So-RISP network aims to structure the PHIR field, consolidating expertise from renowned teams specializing in PHIR, primary cancer prevention, and addiction. In January 2023, So-RISP members convened a national workshop.
View Article and Find Full Text PDFAllergy
January 2025
Pneumology Pediatric Allergology, CHU Toulouse Purpan, Toulouse, France.
BMJ
November 2024
University of Rennes, CHU Rennes, Inserm, EHESP, Irset, Centre d'investigation clinique de Rennes, Rennes, France.
Infect Dis Now
November 2024
Service des Maladies Infectieuses et Tropicales, Hôpital de Melun-Sénart, France.
NPJ Parkinsons Dis
November 2024
Champalimaud Research and Clinical Centre, Champalimaud Foundation, Av. Brasília, 1400-038, Lisboa, Portugal.
Resting tremor (RT) is a Parkinson's disease (PD) symptom with an unclear relationship to the dopaminergic system. We analysed data from 432 subjects from the Parkinson's Progression Markers Initiative, 57 additional PD patients and controls and 86 subjects referred for dopamine transporter single-photon emission computed tomography (DaT-SPECT). Caudate binding ratio (CBR), but not putamen binding ratio, was higher in RT patients.
View Article and Find Full Text PDFJPEN J Parenter Enteral Nutr
January 2025
Faculty of Biology and Medicine, Lausanne University, Lausanne, Switzerland.
Lab Invest
January 2025
Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion, Saint-Denis, France; Service d'Anatomie et Cytologie Pathologiques, CHU de La Réunion site SUD-Saint-Pierre, Saint-Pierre Cedex, France; Tumorothèque régionale de La Réunion, CHU de La Réunion site SUD-Saint-Pierre, Saint-Pierre Cedex, France. Electronic address:
CD248 (endosialin/tumor endothelial marker 1) is upregulated in cancer, including colorectal cancer (CRC), but its exact role in tumor progression remains to be elucidated. Previous studies have shown that the extracellular domain of CD248 mediates the interaction between tumor cells and extracellular matrix proteins and that interfering with this interaction may reduce tumor invasion and migration activities. We have examined the expression of CD248 in 117 human CRC samples by immunohistochemistry and investigated the association with various clinicopathologic features, including the occurrence of metastasis, intratumoral immune cell density and overall survival.
View Article and Find Full Text PDFTherapie
October 2024
Université de Grenoble Alpes, Inserm, CIC1406, HP2 U1300, CHU Grenoble Alpes, 38043 Grenoble, France. Electronic address:
Kidney Int Rep
November 2024
Universite Paris Est Creteil, INSERM IMRB U955, Créteil, France.
Front Oncol
October 2024
Radiation Oncology Department, Georges Pompidou European Hospital, Assistance Publique - Hôpitaux de Paris, Paris Descartes University, Paris Sorbonne Cité, Paris, France.
Background: Nodes are the second site for prostate cancer recurrence. Whole-pelvic radiotherapy (WPRT) has shown superiority over nodal stereotactic body radiotherapy (SBRT) in two retrospective cohorts. We aimed to compare both modalities and assess factors associated with treatment outcomes.
View Article and Find Full Text PDFSpectrochim Acta A Mol Biomol Spectrosc
February 2025
Biopathologie de la Myéline, Neuroprotection et Stratégies Thérapeutiques, UMR_S1119, Faculty of Medicine, University of Strasbourg, 1, Rue Eugène Boeckel, 67000 Strasbourg, France; Centre d'Investigation Clinique de Strasbourg (CIC), INSERM 1434, bâtiment CRBS, 1, Rue Eugène Boeckel, 67000 Strasbourg, France. Electronic address:
Disease modifying therapies including interferon-β (IFNβ) effectively counteract the inflammatory component in relapsing-remitting multiple sclerosis (RRMS) but this action, generally associated with severe side effects, does not prevent axonal/neuronal damages. Hence, axonal neuroprotection, which is pivotal for MS effective treatment, remains a difficult clinical challenge. Growing evidence suggested as promising candidate for neuroprotection, Emapunil (AC-5216) or XBD173, a ligand of the mitochondrial translocator protein highly expressed in glial cells and neurons.
View Article and Find Full Text PDFEur J Immunol
December 2024
Nantes Université, CHU Nantes, INSERM, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, ITUN, Nantes, France.
The use of immunosuppressive treatment is required to prevent rejection events, even a long time after kidney transplantation despite rare recipients achieving long-term graft stability without the need for immunosuppressive treatment, called operationally tolerant patients (TOLs). We comprehensively investigate the immune system of long-term IS recipients (LTTs) and TOLs to highlight their shared and unique immune features. Blood immune cell phenotyping was performed by spectral cytometry.
View Article and Find Full Text PDFFront Hum Neurosci
October 2024
Université de Franche-Comté, INSERM, UMR 1322 LINC, Besançon, France.
Introduction: This systematic review explores the use of neurophysiological measurements to study emotional responses to cosmetic products. The aim is to evaluate existing literature on these measurements in cosmetics, identify the main findings, highlight methodological challenges, and propose new guidelines for future research.
Method: A systematic search focusing on neurophysiological measures to determine emotions induced by different cosmetic products was carried out in accordance with PRISMA guidelines.
Clin Interv Aging
November 2024
Department of Geriatrics, University of Montpellier, Montpellier, France.
Background: The effects on gait and posture of balneotherapy in fallers are unknown. We assessed the effects on physical functioning and fear of falling of a balneotherapy program alone or combined with a physical activity and educational program in older adult fallers.
Methods: A multicenter randomized controlled trial enrolled patients aged 65 or older referred to a 3-week balneotherapy program, and screened for risk of falling (a history of falls in the last year and a timed up and go test or a five chair rising test >12 sec or a 4-meter walk test >4 sec).
Rev Neurol (Paris)
October 2023
Service de Neurologie, CHRU Cavale-Blanche, Brest, France; Université Brest, Inserm, EFS, UMR 1078, GGB, 29200 Brest, France. Electronic address:
JMIR Pediatr Parent
November 2024
Centre d'Investigation Clinique 1410 - INSERM, University Hospital Center, Saint-Pierre, Reunion.
Background: Sexual health indicators for adolescents and young adults (AYAs) aged between 13 and 25 years are particularly poor on Reunion Island. Access to accurate information as well as sexual health and contraceptive services are vital to maintaining sexual well-being. Teleconsultations offer a promising approach to addressing the sexual health and contraceptive needs of AYAs who are more susceptible to engaging in unprotected sexual intercourse.
View Article and Find Full Text PDFAm J Obstet Gynecol
October 2024
Department of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux, France. Electronic address:
ESMO Open
November 2024
Department of Medical Oncology, Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Residual Tumor and Response to Treatment, RT2Lab, INSERM, U932 Cancer & Immunity, Institut Curie, Université Paris Sciences Lettres, Paris, France; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance Publique - Hôpitaux de Paris (AP-HP), Centre d'Investigation Clinique (CIC-1901), Pharmacology Department, Pitié-Salpêtrière Hospital, Paris, France. Electronic address:
Front Ophthalmol (Lausanne)
October 2024
Biosciences Institute, Newcastle University, Newcastle, United Kingdom.
Blood
January 2025
Service de Médecine Interne, Centre National de Référence des Cytopénies Auto-Immunes de l'Adulte, Centre Hospitalier Universitaire Henri Mondor, Université Paris Est-Créteil, Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique-Hôpitaux de Paris, Créteil, France.
In an open prospective, multicenter study enrolling 48 selected patients with chronic immune thrombocytopenia who achieved complete response for 1 year on thrombopoietin receptor agonists, half of the patients maintained a sustained response off treatment 4 years after treatment discontinuation.
View Article and Find Full Text PDFHemasphere
November 2024
Université Paris Cité and Université des Antilles, INSERM, BIGR Paris France.